Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Surgery Partners, Inc., The Ensign Group or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Surgery Partners, Inc., The Ensign Group and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Surgery Partners, Inc., The Ensign Group and Inc.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Latest Health Care Providers & Services and Surgery Partners, Inc., The Ensign Group, Inc. Stock News

As of September 2, 2026, Surgery Partners, Inc. had a $1.8 billion market capitalization, compared to the Health Care Providers & Services median of $1.7 million. Surgery Partners, Inc.’s stock is NA in 2026, NA in the previous five trading days and down 38.09% in the past year.

Currently, Surgery Partners, Inc. does not have a price-earnings ratio. Surgery Partners, Inc.’s trailing 12-month revenue is $3.4 billion with a -2.6% net profit margin. Year-over-year quarterly sales growth most recently was 2.7%. Analysts expect adjusted earnings to reach $0.486 per share for the current fiscal year. Surgery Partners, Inc. does not currently pay a dividend.

Currently, The Ensign Group, Inc.’s price-earnings ratio is 27.1. The Ensign Group, Inc.’s trailing 12-month revenue is $5.5 billion with a 6.9% net profit margin. Year-over-year quarterly sales growth most recently was 17.3%. Analysts expect adjusted earnings to reach $7.794 per share for the current fiscal year. The Ensign Group, Inc. currently has a 0.2% dividend yield.

How We Compare Surgery Partners, Inc., The Ensign Group and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Surgery Partners, Inc., The Ensign Group and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Surgery Partners, Inc., The Ensign Group and Inc. Growth Grades

Company	Ticker	Growth
Surgery Partners, Inc.	SGRY	A
The Ensign Group, Inc.	ENSG	A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Surgery Partners, Inc. has a Growth Score of 89, which is Very Strong. The Ensign Group, Inc. has a Growth Score of 89, which is Very Strong.

The Growth Grade Winner: It’s a Tie!

Looking at the Growth Grade breakdown above, both Surgery Partners, Inc., The Ensign Group and Inc. have a grade of A. For investors who focus solely on a company’s upward growth, further research should be conducted into both companies’ other financial metrics before deciding whether to invest.

Surgery Partners, Inc., The Ensign Group and Inc.’s Momentum Grades

Company	Ticker	Momentum
Surgery Partners, Inc.	SGRY	D
The Ensign Group, Inc.	ENSG	C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Surgery Partners, Inc. has a Momentum Score of 21, which is Weak. The Ensign Group, Inc. has a Momentum Score of 46, which is Average.

The Momentum Stock Winner: No Clear Winner

Neither Surgery Partners, Inc., The Ensign Group or Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Surgery Partners, Inc., The Ensign Group or Inc. is the better investment when it comes to momentum.

Surgery Partners, Inc., The Ensign Group and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Surgery Partners, Inc.	SGRY	B
The Ensign Group, Inc.	ENSG	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Surgery Partners, Inc. has a Earnings Estimate Score of 64, which is Positive. The Ensign Group, Inc. has a Earnings Estimate Score of 54, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Surgery Partners, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Surgery Partners, Inc. has a better Earnings Estimate Revisions Grade than The Ensign Group, Inc.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Surgery Partners, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Surgery Partners, Inc., The Ensign Group and Inc. Grades

In addition to Momentum, Estimate Revisions and Growth, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Surgery Partners, Inc., The Ensign Group and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Surgery Partners, Inc., The Ensign Group or Inc. Stock?

Overall, Surgery Partners, Inc. stock has a Growth Score of 89, Momentum Score of 21 and Estimate Revisions Score of 64.

The Ensign Group, Inc. stock has a Growth Score of 89, Momentum Score of 46 and Estimate Revisions Score of 54.

Comparing Surgery Partners, Inc., The Ensign Group and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.